8-KEarnings & ResultsExhibits & Filings

GE HealthCare Technologies Inc. 8-K Report, Financial Results (Feb 13, 2025)

Filed February 13, 2025For Securities:GEHC

Summary

GE HealthCare Technologies Inc. (GEHC) filed an 8-K on February 13, 2025, to announce its fourth quarter and full fiscal year 2024 financial results. The primary purpose of this filing is to furnish the accompanying press release, which contains the detailed financial performance and operational updates. Investors should refer to the press release (Exhibit 99) for specific metrics regarding revenue, profitability, segment performance, and any forward-looking guidance provided by the company. This report serves as a notification of the release of these results and does not represent new material information beyond what is contained in the furnished press release. The information is provided under Item 2.02 and is considered "furnished," not "filed," meaning it does not carry the same liability implications as a formally filed document under Section 18 of the Exchange Act. Investors are advised to review the press release for a comprehensive understanding of GE HealthCare's recent performance and outlook.

Key Highlights

  • 1GE HealthCare announced its Q4 and full-year 2024 financial results on February 13, 2025, via an 8-K filing.
  • 2The core of the filing is the press release (Exhibit 99) containing the detailed financial results.
  • 3Investors should consult Exhibit 99 for specific figures on revenue, earnings, and segment performance for Q4 and FY2024.
  • 4The filing indicates the company may have provided updated financial guidance or commentary on its performance outlook.
  • 5Information furnished under Item 2.02 is for disclosure purposes and is not deemed "filed" under Section 18 of the Exchange Act.
  • 6This 8-K acts as a notification mechanism for the release of earnings, directing investors to the press release for substantive details.

Frequently Asked Questions

The primary purpose of this 8-K filing is to formally announce and provide access to GE HealthCare's fourth quarter and full fiscal year 2024 financial results through an accompanying press release (Exhibit 99).

All detailed financial results, including revenue, earnings, segment performance, and potentially forward-looking guidance, are contained within the press release furnished as Exhibit 99 to this 8-K filing.

The information furnished pursuant to Item 2.02, including the press release, is considered 'furnished' and not 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. This means it is provided for disclosure but does not carry the same legal liabilities as formally filed information.

Investors should look for key metrics such as total revenue, revenue growth (both reported and organic), gross profit margins, operating income, net income, earnings per share (EPS), and performance details across GE HealthCare's major business segments (e.g., Imaging, Ultrasound, Enterprise Innovations, and Pharmaceutical Diagnostics).